Distributional Cost-Effectiveness Analysis comes of age

Richard Andrew Cookson, Susan Griffin, Ole F Norheim, Anthony J Culyer, Kalipso Chalkidou

Research output: Contribution to journalArticlepeer-review


Distributional Cost-Effectiveness Analysis (DCEA) provides information about the equity impacts of health technologies and programmes
It can provide distributional breakdowns of effects and opportunity costs by equity-relevant social variables and/or disease categories
It can also use equity weights to summarise equity impacts and analyse trade-offs between equity and efficiency
This editorial describes recent developments in DCEA
New training resources and professional networks are provided
Original languageEnglish
Number of pages12
JournalValue in Health
Early online date7 Nov 2020
Publication statusE-pub ahead of print - 7 Nov 2020

Bibliographical note

This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy.


  • Cost-Benefit Analysis
  • Socioeconomic Factors
  • Health Equity
  • Technology Assessment, Biomedical

Cite this